Exercise training improves high-density lipoprotein-mediated transcription of proangiogenic microRNA in endothelial cells

European Journal of Preventive Cardiology

Volumn 22, Issue 7, 2015, Pages 899-903

  Riedel, Saskia ^a   Radzanowski, Stephan ^a   Bowen, T Scott ^a   Werner, Sarah ^a   Erbs, Sandra ^a   Schuler, Gerhard ^a   Adams, Volker ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

chronic heart failure; exercise training; High density lipoprotein; microRNA

Indexed keywords

HIGH DENSITY LIPOPROTEIN; MICRORNA; MICRORNA 126; MICRORNA 21; MICRORNA 214; MICRORNA 221; MICRORNA 222; NITRIC OXIDE; MIRN126 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETER; BIOAVAILABILITY; BLOOD SAMPLING; CARDIAC PATIENT; CELL CULTURE; CHOLESTEROL TRANSPORT; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; EXERCISE; EXERCISE TEST; HEART FAILURE; HUMAN; HUMAN CELL; NEW YORK HEART ASSOCIATION CLASS; NONPARAMETRIC TEST; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WORKLOAD; ANGIOGENESIS; BLOOD; CASE CONTROL STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; GENETIC TRANSCRIPTION; GENETICS; KINESIOTHERAPY; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TIME FACTOR; TREATMENT OUTCOME; UPREGULATION;

AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; ENDOTHELIAL CELLS; EXERCISE THERAPY; FEMALE; HEART FAILURE; HUMANS; LIPOPROTEINS, HDL; MALE; MICRORNAS; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME; UP-REGULATION;

EID: 84930591226     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314541036     Document Type: Article

References (26)

1. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol. 2001 ; 12: 383-389
2. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 ; 62: 707-714
3. Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009 ; 302: 1993-2000
4. Rye KA, Bursill CA, Lambert G, et al. The metabolism and anti-atherogenic properties of HDL. J Lipid Res. 2009 ; 50: S195 - S200
5. Navab M, Reddy ST, Van Lenten BJ, et al. HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011 ; 8: 222-232
6. Besler C, Heinrich K, Rohrer L, et al. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest. 2011 ; 121: 2693-2708
7. Adams V, Besler C, Fischer T, et al. Exercise training in patients with chronic heart failure promotes restoration of HDL functional properties. Circ Res. 2013 ; 113: 1345-1355
8. Valacchi G, Sticozzi C, Lim Y, et al. Scavenger receptor class B type I: A multifunctional receptor. Ann N Y Acad Sci. 2011 ; 1229: E1 - E7
9. Yuhanna IS, Zhu Y, Cox BE, et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med. 2001 ; 7: 853-857
10. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004 ; 116: 281-297
11. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011 ; 469: 336-342
12. Uhlemann M, Möbius-Winkler S, Fikenzer S, et al. Circulating microRNA-126 increases after different forms of endurance exercise in healthy adults. Eur J Prev Cardiol. 2014 ; 21: 484-491
13. Mooren FC, Viereck J, Krüger K, et al. Circulating micrornas as potential biomarkers of aerobic exercise capacity. Am J Physiol Heart Circ Physiol. 2014 ; 306: H557 - H563
14. Wang S, Olson EN. AngiomiRs - key regulators of angiogenesis. Curr Opin Genet Dev. 2009 ; 19: 205-211
15. Hans FP, Moser M, Bode C, et al. MicroRNA regulation of angiogenesis and arteriogenesis. Trends Cardiovasc Med. 2010 ; 20: 253-262
16. Fish JE, Santoro MM, Morton SU, et al. MiR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008 ; 15: 272-284
17. Poliseno L, Tuccoli A, Mariani L, et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood. 2006 ; 108: 3068-3071
18. Kuhnert F, Mancuso MR, Hampton J, et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development. 2008 ; 135: 3989-3993
19. Harris TA, Yamakuchi M, Ferlito M, et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA. 2008 ; 105: 1516-1521
20. Weber M, Baker MB, Moore JP, et al. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun. 2010 ; 393: 643-648
21. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008 ; 456: 980-984
22. Roy S, Khanna S, Hussain SR, et al. MicroRNA expression in response to murine myocardial infarction: MiR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 2009 ; 82: 21-29
23. Poliseno L, Tuccoli A, Mariani L, et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood. 2006 ; 108: 3068-3071
24. Felli N, Fontana L, Pelosi E, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA. 2005 ; 102: 18081-18086
25. Dentelli P, Rosso A, Orso F, et al. MicroRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol. 2010 ; 30: 1562-1568
26. Javaheri A, Rader DJ. High-density lipoprotein: NO failure in heart failure. Circ Res. 2013 ; 113: 1275-1277